MP High Court: Estranged Husband Entitled to Loss of Consortium Compensation After Wife’s Death || J&K & Ladakh HC: Claims under Roshni Act Void Ab Initio, Ownership Rights Null from Inception || Madras High Court Directs Expedited Trials in 216 Pending Criminal Cases Against MPs and MLAs || MP High Court: Allowing Minor to Drive Without Valid License Constitutes Breach of Insurance Policy || Punjab & Haryana High Court: Cyber Fraud Cases Uphold Public Trust, Cannot Be Quashed by Compromise || SC: Customer-Banker Relationship Based on Mutual Trust, Postmaster’s Reinstatement Quashed || Supreme Court: Company Buying Software for Efficiency and Profit Is Not a ‘Consumer’ under CPA || SC: Long Custody or Trial Delay Not Ground for Bail in Commercial Narcotic Cases if S.37 Unmet || Calcutta HC Disqualifies Politician Mukul Roy from Assembly under Anti-Defection Law || Supreme Court Bans Mining in and Around National Parks and Wildlife Sanctuaries

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :